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Human Pythiosis
To the Editor: Over the past 2
decades, human pythiosis has
emerged as an important parafungal
disease; Thailand reports the most
cases (1,2). Given the rarity of this
infection in humans and the limited
attention of researchers to the disease,
our understanding of its pathogenesis
and other important traits, including
its management, await investigation.
We report 2 distinct cases.
The first patient was a 63-year-old
woman with hemoglobin AEBart’s
disease, a complex thalassemia/
hemoglobinopathy syndrome, which
required frequent blood transfusions.
Two months before admission, after a
major flood and exposure to standing
water for weeks, an abnormal sensa-
tion developed in her right foot, which
progressed to pain and intermittent
claudication. Subsequent inability to
walk prompted her to seek medical
assistance. At admission, she was
febrile with absence of pulses on the
right lower extremity and a dimin-
ished pulse on the left. She had a
peripheral blood eosinophilia of 10%.
Emergency femoral angiography indi-
cated complete obstruction of the
right common iliac and left internal
iliac arteries (Figure) with collateral
supplies via lumbar arteries. Surgical
intervention demonstrated a white
clot from aortic bifurcation down to
the right common iliac artery and the
superficial and deep femoral arteries,
surrounded by necrotic tissue and
enlarged inguinal nodes. Right
femoral embolectomy and aorto-
femoral bypass were performed. A
10% KOH preparation of the clot and
dissected nodes showed branching
septate hyphae. 
Cultures of these specimens grew
Pythium insidiosum. Itraconazole
solution, terbinafine, and therapeutic
vaccines (3) were administered.
Extended-spectrum antimicrobial
agents were also given during her hos-
pital stay to combat nosocomial infec-
tions. Progressive wound necrosis and
gangrene of the limbs dictated multi-
ple debridements and subsequent limb
amputations and hip disarticulation.
Her clinical course worsened, and she
died 2 months after admission. 
The second patient was a 15-year-
old boy with β-thalassemia/hemoglo-
bin E disease, 10 years after splenec-
tomy. The patient received frequent
blood transfusions and monthly intra-
venous deferoxamine for secondary
hemochromatosis. Six days before
admission to our hospital, necrotizing
cellulitis of both legs, unresponsive to
intravenous antimicrobial agents, was
diagnosed at a local hospital. The
patient reported frequent swimming
in standing water in rice fields. He
was febrile with a leukocyte count of
26,000/mm3 and was given broad-
spectrum intravenous antimicrobial
agents. Severity of the lesions
demanded surgical debridement
(online Appendix Figure, available
from http://www.cdc.gov/ncidod/ EID/
vol12no03/05-1044-appG.htm), which
showed necrosis of skin and subcuta-
neous tissue but intact fasciae and
muscles. Tissue pathology and fungal
staining did not demonstrate the etio-
logic agent. Surgical tissue Gram’s
stain and culture were nonrevealing,
but fungal culture grew P. insidiosum
after a few days. Isolates demonstrat-
ed white submerged colonies and
microscopically showed sparsely sep-
tate hyphae 4–10 µm in diameter.
Boiled grass blades were transferred
onto the agar with the growth and
incubated at 37°C for 24 hours. The
blades were then put in a container
with dilute salt solution for 2 hours at
35°C. They were subsequently placed
on a slide, and mobile biflagellate
zoospores were seen. Serum antibod-
ies to P. insidiosum by immunodiffu-
sion were detected in both cases.
Femoral angiography showed no
abnormalities. Since therapeutic
immunogens were not available dur-
ing that period, a combination of
supersaturated potassium iodide
(SSKI), itraconazole, and terbinafine
was initiated. SSKI was discontinued
after a month because of side effects.
Lesions were progressive involving
fasciae and muscles and necessitated
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Figure. Femoral angiography of patient 1 demonstrating involvement of the right common
iliac artery upward to the aorta and extending to the left internal iliac artery.LETTERS
2 episodes of surgical debridement
during the first month. The lesions
began to improve in the second month
of medical therapy, when skin graft-
ing was performed. The patient
remained well and was discharged
after almost 3 months. Medications
were continued for a total period of 6
months. The patient has been well for
>2 years. 
P. insidiosum in tissues resembles
agents of zygomycosis morphologi-
cally but, unlike the latter, rarely stains
with hematoxylin and eosin. Various
immunostainings also help identify
the organism (4). With the exception
of the facial-cranial form of the dis-
ease in the United States (5), most
cases in Thailand occur in patients
with chronic hemolytic anemia; tha-
lassemia-hemoglobinopathy is the
most common underlying disease.
Major clinical manifestations include
ocular and craniofacial infections in
healthy children, arteritis usually orig-
inating from lower extremities, and
chronic subcutaneous abscesses.
Treatment options reported to be
successful include supersaturated
potassium iodide for the chronic cuta-
neous form (2), a combination of
terbinafine and itraconazole in a single
case of an acute, severe ocular, subcu-
taneous infection (6), and therapeutic
vaccination for severe infections
involving major arteries (7,8) in con-
junction with surgery. The first case
suggested that, with chronic pythiosis
involving the aorta, effective manage-
ment is difficult. In the second case,
the laboratory was familiar with P.
insidiosum  isolation procedures;
therefore, a quick diagnosis was made
and early treatment was instituted.
This early form of cutaneous pythiosis
is rarely diagnosed properly by most
clinical and pathologic laboratories.
Human cases probably occur world-
wide (9) but are underrecognized and
thus, misdiagnosed (5). More research
into the pathogenesis, diagnosis, and
new treatment modalities is urgently
needed.
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Rift Valley Fever
Potential, Arabian
Peninsula
To the Editor: Rift Valley fever
(RVF) virus causes severe disease,
abortion, and death in domestic ani-
mals (especially young sheep, cattle,
and goats) in Africa and the Arabian
Peninsula. Humans are infected by
mosquitoes, which maintain epizootic
transmission, or through exposure to
infected animal tissue. Although
human disease may be mild, some-
times severe retinitis, meningoen-
cephalitis, or hemorrhagic fever syn-
dromes may develop in patients. In
Africa, epizootics and associated
human epidemics usually follow
heavy rainfall (1).
RVF was first confirmed outside
Africa in September 2000. The out-
break in southwestern coastal Saudi
Arabia and neighboring coastal areas
of Yemen resulted in an epizootic with
>120 human deaths and major losses
in livestock populations from disease
and slaughter (2,3). RVF virus isolat-
ed from the floodwater mosquito
Aedes vexans arabiensis during the
outbreak was closely related to strains
from Madagascar (1991) and Kenya
(1997), which suggests that the virus
was imported through infected mos-
quitoes or livestock from East Africa
(3). The Arabian outbreak followed
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